[Effect of cyclophosphamide on hematopoietic stem cells in mice with iron overload]

scientific article published on 01 January 2020

[Effect of cyclophosphamide on hematopoietic stem cells in mice with iron overload] is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.12122/J.ISSN.1673-4254.2020.01.18
P932PMC publication ID7040758
P698PubMed publication ID32376555

P2093author name stringXiaoxiao Xu
Yanjun Xu
Xuedong Wu
Fuyu Pei
Yuelin He
Tiantian Yi
P2860cites workBone loss caused by iron overload in a murine model: importance of oxidative stressQ30496963
Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a GruppQ35588325
Pretransplant immunosuppression followed by reduced-toxicity conditioning and stem cell transplantation in high-risk thalassemia: a safe approach to disease controlQ35600557
Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation.Q35692054
The C57BL/6 genetic background confers cardioprotection in iron-overloaded miceQ36569080
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.Q37370649
Busulfan fludarabine vs busulfan cyclophosphamide as a preparative regimen before allogeneic hematopoietic cell transplantation: systematic review and meta-analysisQ38604900
Comparison of two dose levels of cyclophosphamide for successful stem cell mobilization in myeloma patientsQ40081439
Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced-toxicity conditioning regimen according to a new risk stratificationQ41201160
Effect of graft source on unrelated donor hemopoietic stem cell transplantation in adults with acute myeloid leukemia after reduced-intensity or nonmyeloablative conditioning: a study from the Société Francaise de Greffe de Moelle et de Thérapie CelQ41363636
Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemiaQ43263130
The bone marrow hematopoietic microenvironment is impaired in iron-overloaded miceQ43459542
Circulating stem cells in mice treated with cyclophosphamide.Q44538082
Evaluation of hepatic iron overload in Chinese children with β-thalassemia major.Q50525194
EPO receptor, Bax and Bcl-x(L) expressions in murine erythropoiesis after cyclophosphamide treatment.Q50911748
A novel conditioning regimen improves outcomes in β-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation.Q51311674
Cyclophosphamide plus granulocyte-colony stimulating factor for hematopoietic stem cell mobilization in patients with multiple myeloma.Q52919426
Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine.Q53354602
Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation.Q54327926
Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia.Q55037985
Allogeneic hematopoietic stem cell transplantation in congenital hemoglobinopathies with myeloablative conditioning and rabbit anti-thymocyte globulin.Q55445286
Effect of stem cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor on morphology of haematopoietic organs in miceQ61942727
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacityQ64105462
Hematopoietic Stem Cell Transplantation in ThalassemiaQ87820828
Unrelated and related donor transplantation for beta-thalassemia major: A single-center experience from IndiaQ88565545
Improvements in haploidentical transplantation for sickle cell disease and β-thalassaemiaQ92410592
Unrelated Donor Peripheral Blood Stem Cell Transplantation for Patients with β-Thalassemia Major Based on a Novel Conditioning RegimenQ92879165
P433issue1
P921main subjectiron overloadQ2025687
P304page(s)110-117
P577publication date2020-01-01
P1433published inNan fang yi ke da xue xue baoQ26842354
P1476title[Effect of cyclophosphamide on hematopoietic stem cells in mice with iron overload]
P478volume40

Search more.